Genetic S.p.a.

Vincenzo Santagada

Giuseppe Cirino

Giuseppe Caliendo

Beatrice Severino

Ferdinando Fiorino

Fiorentina Roviezzo

Francesco Frecentese

Elisa Perissutti

Antonio Petti

Elisa Magli

Marcelo Nicolas Muscarà

Marcelo Nicolas Muscara'

Marcelo Nicolas Muscara′

The present invention relates to salts of budesonide 21-phosphate with β2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Budesonide 21-phosphate salts and pharmaceutical compositions containing the same

The present invention relates to salts of Montelukast with β2 adrenergic agonists, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.

Montelukast salts and pharmaceutical compositions containing the same

The present invention relates to esters of Montelukast with corticosteroids, preferably with des-ciclesonide, triamcinolone, budesonide or flunisolide, pharmaceutical compositions containing the same and the use thereof in the treatment of several respiratory tract diseases, especially asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The invention further relates to the process for preparing said esters.

Montelukast esters and pharmaceutical compositions containing the same

Growing community of inventors

Naples, Italy

Vincenzo Santagada